The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N01 | Anesthetics | |
| 3 | N01B | Anesthetics, local | |
| 4 | N01BB | Amides | |
| 5 | N01BB04 | Prilocaine |
| Active Ingredient | Description | |
|---|---|---|
| Prilocaine |
Prilocaine is a toluidine derivative and intermediate-acting amino amide with local anesthetic property. Prilocaine binds to the intracellular surface of sodium channels which blocks the subsequent influx of sodium into the cell. Action potential propagation and never function is, therefore, prevented. This block is reversible and when the drug diffuses away from the cell, sodium channel function is restored and nerve propagation returns. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CITANEST PLAIN Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| PRILOTEKAL Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
